Benchmarking R&D success rates of leading pharmaceutical companies: an empirical analysis of FDA approvals (2006-2022)

DSpace Repository

Show simple item record

dc.contributor.author Hartl, Dominik
dc.date.accessioned 2026-02-27T09:29:26Z
dc.date.available 2026-02-27T09:29:26Z
dc.date.issued 2025
dc.identifier.issn 1359-6446
dc.identifier.uri http://hdl.handle.net/10900/176185
dc.language.iso en en
dc.publisher London : Elsevier Sci Ltd de_DE
dc.relation.uri http://dx.doi.org/10.1016/j.drudis.2025.104291
dc.subject.ddc 610 de_DE
dc.title Benchmarking R&D success rates of leading pharmaceutical companies: an empirical analysis of FDA approvals (2006-2022) de_DE
dc.type Article de_DE
utue.quellen.id 20250630000000_02070
utue.personen.roh Schuhmacher, Alexander
utue.personen.roh Hinder, Markus
utue.personen.roh Brief, Elazar
utue.personen.roh Gassmann, Oliver
utue.personen.roh Hartl, Dominik
dcterms.isPartOf.ZSTitelID Drug Discovery Today de_DE
dcterms.isPartOf.ZS-Issue 2 de_DE
dcterms.isPartOf.ZS-Volume 30 de_DE
utue.fakultaet Universität Tübingen (ohne Fakultätsangabe)


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record